Liver-on-a-Chip Market Grows as Demand for Advanced Drug Testing and Disease Modeling Increases | Valuates Reports

Liver-on-a-chip Market
Liver on a Chip. The liver models are designed to mimic the responses of the human liver when used in drug testing.
Market Analysis and Insights: Global Liver-on-a-chip Market
The global Liver-on-a-chip market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-24F5741/Global_Liver_on_a_chip_Market_Size_Status_and_Forecast_2021_2027

Liver-on-a-Chip Market Trends

The Liver-on-a-Chip market size is expanding due to the growing need for accurate in vitro liver models in drug development, toxicology testing, and disease research. These microfluidic devices simulate liver physiology and function, allowing pharmaceutical companies and researchers to study drug metabolism, hepatotoxicity, and liver diseases more effectively. With the rising concerns over animal testing alternatives and the need for personalized medicine, the adoption of Liver-on-a-Chip technology is accelerating, contributing to significant market growth.

In terms of market share, key players are focusing on technological advancements in organ-on-a-chip platforms, integrating 3D cell culture, bioprinting, and artificial intelligence for enhanced predictive modeling. The pharmaceutical and biotechnology sectors are the primary drivers of demand, as early-stage drug testing and precision medicine become increasingly reliant on organ-mimicking models. While North America leads the market due to strong research funding and regulatory support, Asia-Pacific is witnessing rapid adoption, driven by expanding biotech infrastructure and government investments in healthcare innovation.

A detailed market analysis suggests that continued advancements in microfluidics, stem cell research, and lab-on-a-chip technology will shape the industry's future. The Liver-on-a-Chip market revenue is expected to see sustained growth as companies seek cost-effective, ethical, and high-precision alternatives to traditional drug testing methods, ultimately improving drug safety and accelerating pharmaceutical innovation.

Segment by Type

• Child Liver-on-a-chip
• Adult Liver-on-a-chip

Segment by Application

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Other End Users

By Company

Emulate, Tissuse, Hesperos, CN Bio Innovations, Mimetas, Nortis, Kirkstall, Cherry Biotech SAS, Else Else Kooi Laboratory, Micronit Microtechnologies B.V.

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-24F5741/global-liver-on-a-chip

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.